Compare FMC Corp (FMC) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Kimberly Clark Corp — how do they compare? FMC Corp trades at $11.43 (market cap $1.36B), while Kimberly Clark Corp trades at $109.17 (market cap $35.36B). The key difference: Kimberly Clark Corp is far larger — about 26× FMC Corp's market cap, and Kimberly Clark Corp pays the higher dividend (4.81%). Which is the better fit depends on your goals.
| FMC | KMB | |
|---|---|---|
Market Cap | $1.36B | $35.36B |
Sector | Basic Materials | Consumer Staples |
52-Week High | $43.90 | $136.77 |
52-Week Low | $10.72 | $93.05 |
Enterprise Value | $5.50B | $41.90B |
Dividend Yield | 2.95% | 4.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Kimberly-Clark (KMB) trades at $108.92, up 1.97% with a bullish technical signal despite mixed moving averages. The company maintains strong profitability with a 12.8% net income margin and has beaten earnings estimates for three consecutive quarters. Recent developments include the Arbex joint venture and pending Kenvue acquisition, positioning for strategic transformation while maintaining its Dividend King status with consistent payouts.
KMB offers stable income appeal with a 4.5% dividend yield and analyst consensus target of $112.33, suggesting modest upside. Risks include consumer sentiment pressures and margin compression from input costs, but productivity gains and innovation strategy support long-term growth potential for patient investors seeking reliable cash flow.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
